Buchumschlag

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Eric V. Li, Sai K. Kumar, Jonathan A. Aguiar, Mohammad R. Siddiqui, Clayton Neill, Zequn Sun, Edward M. Schaeffer, Anugayathri Jawahar, Ashley E. Ross, Hiten D. Patel
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	BJUI Compass
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
von: Nicole Handa, et al.
Veröffentlicht: (2025)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
von: Austin Drysch, et al.
Veröffentlicht: (2025)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
von: Muhammad Imran, et al.
Veröffentlicht: (2026)

Peak early‐phase enhancement ratio on contrast‐enhanced MRI to differentiate chromophobe renal cell carcinoma from oncocytoma
von: Deanna Thorson, et al.
Veröffentlicht: (2025)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
von: Herbert Lepor, et al.
Veröffentlicht: (2025)

Utilization of cardiopulmonary bypass at radical nephrectomy for renal cell carcinoma with tumour thrombus
von: Chalairat Suk‐Ouichai, et al.
Veröffentlicht: (2024)

Robotic radical prostatectomy in kidney transplant recipients: A propensity‐matched cohort study
von: Jennifer M. Slota, et al.
Veröffentlicht: (2025)

Emerging tools for the early detection of prostate cancer
von: Muhammad Haider, et al.
Veröffentlicht: (2025)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
von: Geneva Pantoja, et al.
Veröffentlicht: (2025)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
von: Samantha Shekar, et al.
Veröffentlicht: (2025)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
von: Jeremy Cheng, et al.
Veröffentlicht: (2025)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
von: Eric Margolis, et al.
Veröffentlicht: (2025)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
von: Abel Tesfai, et al.
Veröffentlicht: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
von: Nikhil Mayor, et al.
Veröffentlicht: (2026)

Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
von: Thomas Philip Cahill, et al.
Veröffentlicht: (2024)

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
von: Stijn M. van den Bosch, et al.
Veröffentlicht: (2026)

A sustainable and expedited ‘One‐Stop’ prostate cancer diagnostic pathway to reduce environmental impact and enhance accessibility
von: Lorenzo Storino Ramacciotti, et al.
Veröffentlicht: (2024)

Incidental crossed fused renal ectopia detected during prostate cancer staging: A photorealistic three‐dimensional rendering
von: Kei Ushijima, et al.
Veröffentlicht: (2025)

Contemporary assessment of diagnostic performance and histologic concordance of renal mass biopsy with surgical pathology
von: Mitchell M. Huang, et al.
Veröffentlicht: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
von: Sophia M. Abusamra, et al.
Veröffentlicht: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
von: Esther H. J. Hamoen, et al.
Veröffentlicht: (2025)

Testosterone nadir and clinical outcomes in patients with advanced prostate cancer: Post hoc analysis of triptorelin pamoate Phase III studies
von: Laurence Klotz, et al.
Veröffentlicht: (2024)

Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
von: Agnieszka Krzyzanowska, et al.
Veröffentlicht: (2024)

Bibliometric analysis of focal therapy in prostate cancer research
von: Mohammed Shahait, et al.
Veröffentlicht: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
von: Ailene E. Corona, et al.
Veröffentlicht: (2026)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
von: Arjun Pon Avudaiappan, et al.
Veröffentlicht: (2024)

Targeted Prostate Health Checks, a novel system to identify men with prostate cancer—A pilot study
von: Stephen Langley, et al.
Veröffentlicht: (2024)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
von: Nadia Rokan, et al.
Veröffentlicht: (2025)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
von: Ruth Pidsley, et al.
Veröffentlicht: (2024)

Incorporating the NICE Cambridge Prognostic Groups and Predict Prostate into a structured informed‐decision making clinic reduces over‐treatment rates of early prostate cancer
von: Vincent J. Gnanapragasam, et al.
Veröffentlicht: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
von: Sofia Mesquita, et al.
Veröffentlicht: (2025)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
von: Ryan Sutherland, et al.
Veröffentlicht: (2024)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
von: Jonathon Dawson, et al.
Veröffentlicht: (2024)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
von: Marcus Sondermann, et al.
Veröffentlicht: (2025)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
von: Muhammad Haider, et al.
Veröffentlicht: (2025)

Potential gains from radical treatment of men with prostate cancer according to life expectancy
von: Sandra Irenaeus, et al.
Veröffentlicht: (2025)

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
von: Alan Priester, et al.
Veröffentlicht: (2024)

Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer
von: Jennifer Dunsmore, et al.
Veröffentlicht: (2024)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
von: Maxwell Louis Sandberg, et al.
Veröffentlicht: (2026)

Multiparametric‐magnetic resonance imaging (mp‐MRI) of the prostate and Urolift: Identifying artefact size, location and clinical implications
von: Cameron James Parkin, et al.
Veröffentlicht: (2024)